Tradestie Institutional Equity Comparison Engine

AHCO vs TNDM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AHCO Overall Edge

AHCO Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AdaptHealth Corp. Common Stock (AHCO) driven by superior Valuation, Growth & Margin, Options & Structure while TNDM counters with relative strength in Momentum & Technical. Fundamentally, AHCO trades at 7.8x Forward P/E with 3.8% operating margin (+10.9% YoY revenue) versus TNDM at N/M Forward P/E and -2.4% operating margin (+13.8% YoY). In options structure, AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro) against TNDM sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AHCO
AHCO 7.8x vs TNDM N/M Fwd P/E
Growth & Margin Winner AHCO
Op Margin 3.8% vs -2.4% ยท YoY +10.9% vs +13.8%
Momentum & Technical Winner TNDM
1Y -20.9% vs -6.8% ยท 52W Pos 24% vs 30%
Options & Structure Winner AHCO
SURGE (12th %ile IV) vs BREAKDOWN (<1st %ile IV)
AHCO NASDAQ
AdaptHealth Corp. Common Stock
Services-Home Health Care Services
$7.20
-0.69% 1D
Market Cap $989.8M
1M Return +16.69%
1Y Return -20.88%
Forward P/E 7.8x
Unified AI Score
45.2 / 100 HOLD
Tech 29.0 Fund 46.0 Flow 54.0 Mom 60.0
TNDM NASDAQ
Tandem Diabetes Care, Inc.
Surgical & Medical Instruments & Apparatus
$17.46
+3.93% 1D
Market Cap $1.2B
1M Return +1.81%
1Y Return -6.83%
Forward P/E N/M
Unified AI Score
43.3 / 100 HOLD
Tech 54.0 Fund 50.0 Flow 70.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AHCO -20.88% TNDM -6.83% Spread: +14.05 pp (TNDM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AHCO Revenue TNDM Revenue AHCO Op. Margin TNDM Op. Margin Margin Edge
FY2018 $350M $180M 9.0% -24.3% AHCO
FY2019 $530M $360M 5.5% -4.6% AHCO
FY2020 $1.06B $500M 6.8% -1.6% AHCO
FY2021 $2.45B $700M 9.2% 3.2% AHCO
FY2022 $2.97B $800M 6.4% -11.6% AHCO
FY2023 $3.20B $750M -18.7% -31.2% AHCO
FY2024 $3.26B $940M 8.1% -10.5% AHCO
FY2025 $3.24B $1.01B 2.8% -18.5% AHCO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AHCO (6) vs TNDM (4)
Institutional Metric AHCO TNDM Criterion Row Winner
Market Capitalization Scale $989.8M $1.2B Larger Scale TNDM
Trailing P/E Ratio Valuation 7.8x N/M Lower Multiple AHCO
Forward P/E Ratio Valuation 7.8x N/M Lower Multiple AHCO
Revenue Growth (YoY) Growth +10.9% +13.8% Higher Growth TNDM
Operating Margin (TTM) Profitability 3.8% -2.4% Higher Margin AHCO
Net Profit Margin Profitability -11.8% -4.6% Higher Margin TNDM
Return on Equity (ROE) Capital Efficiency -28.4% -36.7% Higher ROE AHCO
52-Week Range Position Momentum 24% ($5โ€“$13) 30% ($12โ€“$30) Stronger Trend TNDM
Beta / 30D Volatility Risk Regime 0.17ฮฒ ยท 67% Vol 1.07ฮฒ ยท 92% Vol Lower Realized Risk AHCO
Unified Institutional Score Composite Signal 45.2 / 100 (HOLD) 43.3 / 100 (HOLD) Higher Composite AHCO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AHCO vs TNDM Buy Guide
AHCO SURGE
6d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live AHCO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TNDM BREAKDOWN
72d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live TNDM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AHCO nor TNDM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.